Heidi Vanden Brink1, Amy D Willis2, Brittany Y Jarrett1, Annie W Lin1, Steven Soler1, Siân Best1, Erica L Bender1, Andrew K Peppin1, Kathleen M Hoeger3, Marla E Lujan4. 1. Human Metabolic Research Unit, Division of Nutritional Sciences, Cornell University, Ithaca, New York. 2. Department of Statistical Sciences, Cornell University, Ithaca, New York. 3. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York. 4. Human Metabolic Research Unit, Division of Nutritional Sciences, Cornell University, Ithaca, New York. Electronic address: MEL245@cornell.edu.
Abstract
OBJECTIVE: To determine whether sonographic markers of ovarian morphology or male pattern hair growth scores predict androgen levels in women with regular or irregular menstrual cycles. DESIGN: Cross-sectional observational study. SETTING: Clinical research unit. PATIENT(S): Seventy-six women of reproductive age (18-39 years) were evaluated for male-pattern hair growth (using a modified Ferriman-Gallwey scoring system), ovarian morphology (by transvaginal ultrasonography), and total serum testosterone (T) (by liquid chromatography tandem mass spectrometry). INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Regional and total modified Ferriman-Gallwey scores, number of follicles per follicle size category, follicle number per ovary, ovarian volume, ovarian area, stromal to ovarian area ratio, stromal echogenicity index, total testosterone (total T), and menstrual cycle length. RESULT(S): Neither regional nor total modified Ferriman-Gallwey scores correlated with total T concentrations in women with regular or irregular menstrual cycles, as judged by the Least Absolute Shrinkage and Selection Operator technique. By contrast, a sonographic marker (follicle number per ovary 6-9 mm) significantly predicted total T concentrations in women with regular menstrual cycles but not in women with irregular menstrual cycles. CONCLUSION(S): Sonographic markers of ovarian morphology, but not hirsutism scores, predicted total T levels. However, the predictive value of ovarian morphology for total T differed by menstrual cycle status. That sonographic markers did not predict androgen levels in a diverse cohort of women with cycle irregularity suggests the potential for distinct variations in ovarian morphology for androgenic and nonandrogenic types of cycle irregularity. Overall, our findings support that an assessment of ovarian morphology may be helpful in reflecting total T levels.
OBJECTIVE: To determine whether sonographic markers of ovarian morphology or male pattern hair growth scores predict androgen levels in women with regular or irregular menstrual cycles. DESIGN: Cross-sectional observational study. SETTING: Clinical research unit. PATIENT(S): Seventy-six women of reproductive age (18-39 years) were evaluated for male-pattern hair growth (using a modified Ferriman-Gallwey scoring system), ovarian morphology (by transvaginal ultrasonography), and total serum testosterone (T) (by liquid chromatography tandem mass spectrometry). INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Regional and total modified Ferriman-Gallwey scores, number of follicles per follicle size category, follicle number per ovary, ovarian volume, ovarian area, stromal to ovarian area ratio, stromal echogenicity index, total testosterone (total T), and menstrual cycle length. RESULT(S): Neither regional nor total modified Ferriman-Gallwey scores correlated with total T concentrations in women with regular or irregular menstrual cycles, as judged by the Least Absolute Shrinkage and Selection Operator technique. By contrast, a sonographic marker (follicle number per ovary 6-9 mm) significantly predicted total T concentrations in women with regular menstrual cycles but not in women with irregular menstrual cycles. CONCLUSION(S): Sonographic markers of ovarian morphology, but not hirsutism scores, predicted total T levels. However, the predictive value of ovarian morphology for total T differed by menstrual cycle status. That sonographic markers did not predict androgen levels in a diverse cohort of women with cycle irregularity suggests the potential for distinct variations in ovarian morphology for androgenic and nonandrogenic types of cycle irregularity. Overall, our findings support that an assessment of ovarian morphology may be helpful in reflecting total T levels.
Authors: S Cupisti; R Dittrich; H Binder; N Kajaia; I Hoffmann; T Maltaris; M W Beckmann; A Mueller Journal: Exp Clin Endocrinol Diabetes Date: 2007-06 Impact factor: 2.949
Authors: Marla E Lujan; Donna R Chizen; Andrew K Peppin; Stefan Kriegler; David A Leswick; Terri G Bloski; Roger A Pierson Journal: Reprod Biol Endocrinol Date: 2008-07-18 Impact factor: 5.211
Authors: Brittany Y Jarrett; Heidi Vanden Brink; Eric D Brooks; Kathleen M Hoeger; Steven D Spandorfer; Roger A Pierson; Donna R Chizen; Marla E Lujan Journal: Fertil Steril Date: 2019-08-05 Impact factor: 7.329
Authors: Maryam Kazemi; Brittany Y Jarrett; Stephen A Parry; Anna E Thalacker-Mercer; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Annie W Lin; Maryam Kazemi; Brittany Y Jarrett; Heidi Vanden Brink; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan Journal: Nutrients Date: 2019-11-08 Impact factor: 5.717